Health
Ozempic Linked To Lower Alzheimer's Risk In People With Type 2 Diabetes
By NBC News
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal Alzheimer’s & Dementia.
The study adds to evidence tha ...Read more